Sort
51,593 grants matching “hepatitis”
Cryopreservation and nanowarming enables whole liver banking for transplantation, cell therapy and biomedical research
$647,312Erik Brian Finger · University Of Minnesota · R01 · FY2024 · DK
SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis
$647,274Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2024 · DK
Targeting hepatic mitochondrial oxidation to treat NAFLD, NASH and type 2 diabetes
$647,207Gerald I Shulman · Yale University · R01 · FY2025 · DK
HIV and HIV/HCV-Infection, Disease Progression, Oxidative Stress and Antioxidants
$647,084Marianna K Baum · Florida International University · R01 · FY2010 · DA
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
$647,023Sheela Shenoi · Yale University · R01 · FY2021 · DA
Confounder-Corrected Quantitative MRI Biomarkers of Hepatic
$647,003Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2017 · DK
National HIV Behavioral Surveillance System
$646,898Kathleen Reilly · New York City Health/Mental Hygiene · U1B · FY2015 · PS
HIV HCV Coinfection Antiviral Therapy and Fibrosis
$646,848David L Thomas · Johns Hopkins University · R37 · FY2012 · DA
Natural history, risk prediction and cost of cirrhosis in insured Americans.
$646,826Daniela P Ladner · Northwestern University At Chicago · R01 · FY2024 · DK
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$646,826Douglas K Owens · Stanford University · R01 · FY2014 · DA
Genetic Modifiers of CF Liver Disease
$646,822University Of North Carolina Chapel Hill · R01 · FY2005 · DK
Steatotic Liver Promotes Metastatic Niche: Role of Hepatic Stellate Cells
$646,739Ekihiro Seki · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Molecular mechanisms underlying the genetic association between PPP1R3B and hepatic steatosis
$646,698Daniel James Rader · University Of Pennsylvania · R01 · FY2019 · DK
Proteomics of Hepatic Carcinogenesis
$646,644Ruth Hogue Angeletti · Albert Einstein College Of Medicine · R33 · FY2006 · CA
NorthStar Node of the Clinical Trials Network
$646,605Gavin Bart · Hennepin Healthcare Research Institute · UG1 · FY2020 · DA
Genetically Programmed Pancreatic Organoids with Self-Adaptive Multi-Lineage Population Control
$646,474Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2022 · HD
Genetically Programmed Pancreatic Organoids with Self-Adaptive Multi-Lineage Population Control
$646,474Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2023 · HD
Genetic Modifiers of CF Liver Disease
$646,462Michael R Knowles · Univ Of North Carolina Chapel Hill · R01 · FY2006 · DK
Donor Red Blood Cell Survival in Recipients with Sickle Cell Disease
$646,383Marianne Elaine McPherson Yee · Emory University · R01 · FY2025 · HL
Novel IP6K1 inhibitors for treatment of NAFLD/NASH
$646,254Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2024 · DK
A Multi-Center Group to Study Acute Liver Failure in Children
$646,209Robert H Squires · Children'S Hosp Pittsburgh/Upmc Hlth Sys · U01 · FY2006 · DK
Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes: The B2D Trial
$646,163John P. Kirwan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · DK
Phase II trial of tesamorelin for cognition in aging HIV-infected persons
$646,035Ronald J. Ellis · University Of California, San Diego · R01 · FY2019 · AG
Conserved Fetal Epigenomic and Metagenomic Signatures in a Primate Model of Maternal Obesity
$645,963Kjersti Marie Aagaard-Tillery · Baylor College Of Medicine · R01 · FY2020 · DK
Mechanisms of T Cell Quiescence and Exhaustion
$645,962Surojit Sarkar · Seattle Children'S Hospital · R01 · FY2025 · AI